Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial ...

The “Know More Sooner” website provides the benefits and dispels the common myths of prenatal genetic testing, as well as where to get screened and what actions can be taken in the instance of ...

Despite advancements in prenatal genetic screening, current medical technology cannot identify all genetic conditions in fetuses. Screening detects chromosomal abnormalities and specific single ...

Prenatal genetic screening is commonly used to identify pregnancies at high risk for birth defects, including neural tube defects and genetic conditions such as Down syndrome. In contrast to other ...

Recently, the introduction of “cell-free fetal DNA testing” has altered the landscape of prenatal genetic testing further. You may have heard of these tests by their brand names: Harmony or ...

Diagnosis of prenatal-onset skeletal dysplasias can be accomplished by ultrasound evaluation and confirmed by both molecular testing using ... whose fetuses have a genetic disorder or significant ...

Inc. (MYGN), a genetic testing and precision medicine company, on Wednesday announced its groundbreaking study results on the Prequel Prenatal Screen with AMPLIFY technology, which enables ...

The study found that Prequel ® Prenatal Screen with AMPLIFY™ technology enables reliable results as early as eight-weeks’ gestation. Typically, prenatal cell-free DNA (pcfDNA) screening is offered ...

It serves purposes like diagnosis, predicting disease risk, assessing carrier status, prenatal screening, and studying how ...

New guidelines were approved Feb. 18 to expand the number of certified medical institutions that can provide prenatal genetic screening to detect chromosomal abnormalities in fetuses. Non-invasive ...

SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...

SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...